Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
NECLIFE Stock Analysis
Views
Red Flags
Positive
Low Debt to Equity, not much change from last year
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis
Weak price momentum
Low and declining ROE
Low and declining operating margin
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Company's earnings are of moderate quality
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.382075.
Snapshot
See detailed analysis
NECLIFE Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
NECLIFE Bulk, Block & Insider Trades
NECLIFE Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Stock split
Others
Stock split(1 : 10)Nominal value changes from Rs 10 to Rs 1 Ex-date: 12th Nov 2008 Announced on: 28th Aug 2008
Share Buyback"On Market Tender Offer." Ex-date: 24th Dec 2025 Announced on: 3rd Dec 2025
Company Profile
Nectar Lifesciences Limited is an India-based pharmaceutical company. The Companys business areas include active pharmaceutical ingredients (APIs) and intermediates, formulations/finished dosage formulations (FDF), menthol and mint derivatives, and empty hard gelatin capsules. The Company is engaged... Read More
Key personnel
Mr. Sanjiv GoyalD
Executive Chairman of the Board, Managing Director
Mr. Amit Chadah
Chief Executive Officer
Mr. Sushil KapoorD
Additional Director( Whole-Time Director), Director (Finance)
Mr. Sanjaymohan Singh Singh Rawat
Company Secretary and Compliance Officer
Dr. Surulichamy SenthilkumarD
Wholetime Director - R&D
Dr. Indu Pal Kaur, Ph.D.D
Additional Independent (Woman) Director
Dr. Kuldip Kumar BhasinD
Independent Non-Executive Director
Dr. Rupinder TewariD
Independent Non-Executive Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently Asked Questions about NECLIFE
What is the current share price of Nectar Lifesciences Ltd.?
The current share price of Nectar Lifesciences Ltd. is ₹ 12.27 as of 24 Feb 2026.
What is the PE ratio of Nectar Lifesciences Ltd.?
The Price-to-Earnings (PE) ratio of Nectar Lifesciences Ltd. is - as of the latest financial data.
What is the ROE and ROCE of Nectar Lifesciences Ltd.?
Nectar Lifesciences Ltd. has a Return on Equity (ROE) of -40.28% and a Return on Capital Employed (ROCE) of -15.26% as per the latest financial reports.
What is the market cap of Nectar Lifesciences Ltd.?
The market capitalization of Nectar Lifesciences Ltd. stands at ₹ 238.36 Cr.
What is the dividend yield of Nectar Lifesciences Ltd.?
The dividend yield of Nectar Lifesciences Ltd. is 0.00% based on the current market price.
What is the RSI of Nectar Lifesciences Ltd.?
The Relative Strength Index (RSI) of Nectar Lifesciences Ltd. is 23.81.
What is the FII and DII holding in Nectar Lifesciences Ltd.?
Foreign Institutional Investors (FII) hold 0.52% and Domestic Institutional Investors (DII) hold 0.00% of Nectar Lifesciences Ltd. shares.
What sector does Nectar Lifesciences Ltd. belong to?
Nectar Lifesciences Ltd. operates in the Healthcare sector.
What is the beta of Nectar Lifesciences Ltd. stock?
The beta of Nectar Lifesciences Ltd. stock is 1.04, indicating its volatility relative to the broader market.
